Gerard Brophy
Chair of Scientific Advisory BoardDr. Gerard Brophy, PhD. also known as Ger, served as Executive Vice President of Biopharma Production at Avantor Inc. until February 29, 2024. Dr. Brophy served as Interim CEO & Director of ElevateBio, LLC from May 12, 2025 until January 2026. Dr. Brophy served as Executive Vice President of Biopharma Production at Avantor, Inc. since July 30, 2018 until October 02, 2023 and serves as its Chair of Scientific Advisory Board since September 2023. Dr. Brophy has extensive experience developing and commercializing products used in biopharma production, including cell culture media, sterile fluid transfer, excipients and other production chemicals. Dr. Brophy joined Avantor from GE Healthcare, medical technology and life sciences company where he spent in a variety of senior level positions, most recently as the Head of Cell Therapy, Life Sciences from January 2017 to July 2018, Chief Technology Officer, Life Sciences from April 2013 to January 2017 and VP of New Product Development, Medical Diagnostics from July 2009 to March 2013. Dr. Brophy served as Director at Drawbridge Health, Inc. Dr. Brophy served as General Manager of Advanced Systems of GE Healthcare Ltd. Dr. Brophy earned a B.S. in biotechnology and a Ph.D. in molecular biology from Dublin City University in Dublin, Ireland.
Positions
- Company NameAvantor, Inc.Stock CodeAVTRPositionChair of Scientific Advisory BoardColleagues
- ELEmmanuel LignerPresident, CEO & Director
- GLGregory L. SummeIndependent Chairman of the Board
- COClaudius O. SokenuExecutive VP, Corporate Secretary and Chief Legal & Compliance Officer
- CDCorey D. WalkerPresident of Laboratory Solutions
- BGBenoit GourdierExecutive Vice President of Bioscience Production
- TWTodd W. GarnerExecutive VP & CFO
- MEMichael E. SeverinoIndependent Director
- JRJoseph R. MassaroIndependent Director
